Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
Category: Health Insurance and Managed Care
-
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
The New York Times – Business: -
Tips for Traveling While Pregnant
The New York Times – Travel:Doing research and getting advice from your doctor before you go can make your trip smoother.
-
Republicans Are Trying to Hide These Health Care Cuts
The New York Times – On the Runway:Republicans are taking deliberate steps to make health care less affordable.
-
What’s Next for Luigi Mangione After His Guilty Plea?
The New York Times – On the Runway:Mr. Mangione’s plea in the federal case could make it difficult for New York State prosecutors to try their own case.
-
Outrage at UnitedHealth and Other Insurers Persists After Brian Thompson Killing
The New York Times – Business:Higher premiums and rising medical bills have intensified Americans’ dissatisfaction with their medical coverage.
-
Ocasio-Cortez Says She Is Freezing Her Eggs and Still Mulling a Presidential Run
The New York Times – On the Runway:In a TV interview, Representative Alexandria Ocasio-Cortez distanced herself from positions like “defund the police” and indicated she hasn’t ruled out a presidential or Senate run.
-
Medicare Advantage’s Perks Are Getting Scrutiny
The New York Times – Business:Officials said no to health plans that wanted to expand extra benefits to cover medical marijuana, streaming services and shopping clubs. More changes are coming in 2027.
-
After Obamacare Cuts, Hospitals Are Treating More Uninsured Patients
The New York Times – Business:More people who lost coverage after congressional Republicans ended enhanced federal subsidies are now seeking care in emergency rooms and unable to pay bills.
-
Health Insurance Giants Are Fighting Efforts to Break Them Up
The New York Times – Business:UnitedHealth Group, CVS Health and Cigna are suing states over new laws targeting their pharmacy businesses.
-
Insurers’ Delays in Approving Medical Care Persist, Despite Promises
The New York Times – Business:Doctors and patients complain that the controversial practice of prior authorization for treatment and procedures is still widespread.
-
Medicare Coverage for GLP-1 Weight Loss Drugs: Cost, Eligibility and What to Know
The New York Times – Business:What you should know about the federal government’s pilot program offering GLP-1s solely for weight loss.